General Information of Drug (ID: DMG77O2)

Drug Name
Efavaleukin alfa
Synonyms AMG592
Indication
Disease Entry ICD 11 Status REF
Systemic lupus erythematosus 4A40.0 Phase 2 [1]
Ulcerative colitis DD71 Phase 2 [2]
Drug Type
Fusion Protein
Cross-matching ID
TTD ID
D1NDO8
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 ClinicalTrials.gov (NCT04680637) A Phase 2b Dose Ranging Study to Evaluate the Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus Erythematosus With Inadequate Response to Standard of Care Therapy. U.S.National Institutes of Health.
2 ClinicalTrials.gov (NCT04987307) A Phase 2, Dose-finding, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Safety and Efficacy of Efavaleukin Alfa Induction Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis. U.S.National Institutes of Health.